Zattarin, E.; Leporati, R.; Ligorio, F.; Lobefaro, R.; Vingiani, A.; Pruneri, G.; Vernieri, C.
Hormone Receptor Loss in Breast Cancer: Molecular Mechanisms, Clinical Settings, and Therapeutic Implications. Cells 2020, 9, 2644.
https://doi.org/10.3390/cells9122644
AMA Style
Zattarin E, Leporati R, Ligorio F, Lobefaro R, Vingiani A, Pruneri G, Vernieri C.
Hormone Receptor Loss in Breast Cancer: Molecular Mechanisms, Clinical Settings, and Therapeutic Implications. Cells. 2020; 9(12):2644.
https://doi.org/10.3390/cells9122644
Chicago/Turabian Style
Zattarin, Emma, Rita Leporati, Francesca Ligorio, Riccardo Lobefaro, Andrea Vingiani, Giancarlo Pruneri, and Claudio Vernieri.
2020. "Hormone Receptor Loss in Breast Cancer: Molecular Mechanisms, Clinical Settings, and Therapeutic Implications" Cells 9, no. 12: 2644.
https://doi.org/10.3390/cells9122644
APA Style
Zattarin, E., Leporati, R., Ligorio, F., Lobefaro, R., Vingiani, A., Pruneri, G., & Vernieri, C.
(2020). Hormone Receptor Loss in Breast Cancer: Molecular Mechanisms, Clinical Settings, and Therapeutic Implications. Cells, 9(12), 2644.
https://doi.org/10.3390/cells9122644
